Recent evidence suggests that overactivation of ERK1/2 contributes to hyperphosphorylation of tau protein in AD and that suppression of ERK 1/2 phosphorylation may prove a valuable target in AD (Muraleva et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.